Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence ; volume:31 ; number:3 ; day:4 ; month:3 ; year:2023 ; pages:1-11 ; date:3.2023
Supportive care in cancer ; 31, Heft 3 (4.3.2023), 1-11, 3.2023
- Creator
-
Cahir, Caitriona
Bennett, Kathleen
Dombrowski, Stephan U.
Kelly, Catherine M.
Wells, Mary
Watson, Eila
Sharp, Linda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-07658-x
- URN
-
urn:nbn:de:101:1-2408070926589.165010289184
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cahir, Caitriona
- Bennett, Kathleen
- Dombrowski, Stephan U.
- Kelly, Catherine M.
- Wells, Mary
- Watson, Eila
- Sharp, Linda
- SpringerLink (Online service)
Other Objects (12)
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Correction to: Impacts of medication non‑adherence to major modifiable stroke‑related diseases on stroke prevention and mortality: a meta‑analysis
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Correction to: Impacts of medication non‑adherence to major modifiable stroke‑related diseases on stroke prevention and mortality: a meta‑analysis
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Correction to: Impacts of medication non‑adherence to major modifiable stroke‑related diseases on stroke prevention and mortality: a meta‑analysis
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer